EOBvent: Effort of Breathing Guided Ventilator Protocol
Study Details
Study Description
Brief Summary
This pilot study tests the feasibility of using a computerized ventilator management protocol seeking to encourage lung protective ventilation during the acute phase of ventilation, and esophageal manometry based titration of ventilator settings during the weaning phase of ventilation, for children with acute respiratory failure. The investigators hypothesize that such an approach will reduce time on mechanical ventilation, largely by preserving diaphragm muscle function.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Objectives: This pilot study will help refine a computer based ventilator management protocol which will be used in both acute and weaning phases of ventilation for children with acute respiratory failure. The acute phase protocol is an adaptation of the Acute Respiratory Distress Syndrome Network protocol for pediatrics, and the weaning phase involves an esophageal manometry guided weaning protocol based on effort of breathing. The investigators seek to test the safety and feasibility of the protocol recommendations and the software system , and help determine the potential effect size of the intervention to determine feasibility of a randomized controlled trial. They also seek to determine the feasibility and reproducibility of serial diaphragm ultrasound measurements on mechanically ventilated children.
Study Population: All children intubated and mechanically ventilated in the Children's Hospital Los Angeles Pediatric ICU with an anticipated length of intubation > 48 hours will be eligible, with some exclusion criteria based on ability to perform the measurements.
Study methodology: After consent, an esophageal catheter will be placed. A software management tool for ventilator management will be placed at the bedside for each enrolled patient, and recommendations regarding changing ventilator support will be provided to the clinicians every several hours during both acute and weaning phases. When ventilator support is below a threshold, recommendations will be made to perform spontaneous breathing trials. The clinicians will ultimately decide whether to accept or reject the recommendations, and will evaluate the patient before each potential change to the ventilator. The acceptance or rejection of recommendations will be tracked, and used to refine the intervention. Daily diaphragm ultrasound measurements will also be obtained to monitor diaphragm thickness and contractile activity.
Follow up: Clinical outcomes will be followed while in the ICU including re-intubation, medications administered, and ICU length of stay. No follow up after ICU discharge is planned.
Analysis plans: Data will be used to refine the intervention, test the acceptability of protocol recommendations to bedside providers, and determine sample size estimates for a follow up randomized controlled trial. These analyses will be descriptive. A pilot of 40 patients is anticipated.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Intervention Arm Ventilator management using the proposed protocol in both acute and weaning phases. Patients will be managed according the the Ventilator protocol using the esophageal catheter for the weaning phase |
Other: Ventilator protocol
Open loop ventilator management by a computer based protocol
Device: Esophageal Catheter
Esophageal manometry measurements of patient effort of breathing will be used to guide the protocol recommendations
|
Outcome Measures
Primary Outcome Measures
- Percentage of Protocol Recommendations Which Are Accepted by the Clinical Provider [With each protocol recommendation, approximately every 4 hours during the course of mechanical ventilation (up to 28 days)]
The investigators will track the percentage of recommendations which are accepted by providers, as well as the reasons why recommendations were not accepted
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Intubated and mechanically ventilated patients in the Children's Hospital Los Angeles Pediatric ICU
-
Anticipated length of intubation > 48 hours.
-
The primary attending physician approves use of the protocol on the patient.
Exclusion Criteria:
-
Corrected gestational age less than 37 weeks
-
Contraindications to nasoesophageal catheter placement (nasopharyngeal or esophageal abnormalities) or Respiratory Inductance Plethysmography bands (abdominal wall defects such as omphalocele).
-
Significant lower airway obstruction (asthma or bronchiolitis), confirmed by ventilator spirometry
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Children's Hospital Los Angeles | Los Angeles | California | United States | 90027 |
Sponsors and Collaborators
- Children's Hospital Los Angeles
Investigators
- Principal Investigator: Robinder Khemani, MD, Children's Hospital Los Angeles
Study Documents (Full-Text)
More Information
Publications
None provided.- CHLA-14-00473
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail | No exclusion of patients prior to assignment to the intervention. |
Arm/Group Title | Intervention Arm |
---|---|
Arm/Group Description | Ventilator management using the proposed protocol in both acute and weaning phases. Patients were managed according the the Ventilator protocol using the esophageal catheter Ventilator protocol: Open loop ventilator management by a computer based protocol Esophageal Catheter: Esophageal manometry measurements of patient effort of breathing were used to guide the protocol recommendations |
Period Title: Overall Study | |
STARTED | 32 |
COMPLETED | 32 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Intervention Arm |
---|---|
Arm/Group Description | Ventilator management using the proposed protocol in both acute and weaning phases. Patients will be managed according the the Ventilator protocol using the esophageal catheter for the weaning phase Ventilator protocol: Open loop ventilator management by a computer based protocol Esophageal Catheter: Esophageal manometry measurements of patient effort of breathing will be used to guide the protocol recommendations |
Overall Participants | 32 |
Age (months) [Median (Inter-Quartile Range) ] | |
Median (Inter-Quartile Range) [months] |
100.7
|
Sex: Female, Male (Count of Participants) | |
Female |
13
40.6%
|
Male |
19
59.4%
|
Race and Ethnicity Not Collected (Count of Participants) | |
Region of Enrollment (participants) [Number] | |
United States |
32
100%
|
Outcome Measures
Title | Percentage of Protocol Recommendations Which Are Accepted by the Clinical Provider |
---|---|
Description | The investigators will track the percentage of recommendations which are accepted by providers, as well as the reasons why recommendations were not accepted |
Time Frame | With each protocol recommendation, approximately every 4 hours during the course of mechanical ventilation (up to 28 days) |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Intervention Arm |
---|---|
Arm/Group Description | Ventilator management using the proposed protocol in both acute and weaning phases. Patients were managed according the the Ventilator protocol using the esophageal catheter Ventilator protocol: Open loop ventilator management by a computer based protocol Esophageal Catheter: Esophageal manometry measurements of patient effort of breathing were used to guide the protocol recommendations |
Measure Participants | 32 |
Mean (95% Confidence Interval) [percentage adherant] |
76
|
Adverse Events
Time Frame | During ICU admission | |
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | Intervention Arm | |
Arm/Group Description | Ventilator management using the proposed protocol in both acute and weaning phases. Patients were managed according the the Ventilator protocol using the esophageal catheter Ventilator protocol: Open loop ventilator management by a computer based protocol Esophageal Catheter: Esophageal manometry measurements of patient effort of breathing were used to guide the protocol recommendations | |
All Cause Mortality |
||
Intervention Arm | ||
Affected / at Risk (%) | # Events | |
Total | 7/32 (21.9%) | |
Serious Adverse Events |
||
Intervention Arm | ||
Affected / at Risk (%) | # Events | |
Total | 0/32 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Intervention Arm | ||
Affected / at Risk (%) | # Events | |
Total | 0/32 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr Robinder Khemani, Associate Director of Research ACCM |
---|---|
Organization | Children's Hospital Los Angeles |
Phone | 323-361-2376 |
rkhemani@chla.usc.edu |
- CHLA-14-00473